To overcome the above problems, we analyzed the association between SUVmax and EGFR mutation in lung adenocarcinoma patients to clarify the relationship between PET/CT metabolic parameters and EGFR mutation and assist lung function adenocarcinoma targeted therapy. The gene discussed is EGFR; the disease is lung adenocarcinoma.